Ulcerative Colitis
Landos Biopharma secures $60M Series B round for IBD treatment
Top stories in gastroenterology: Future of colorectal cancer screening, separating fact from fiction in a patient with Crohn’s disease
Among the top stories in gastroenterology last week were a video interview from GI Outlook 2019 that focused on the future of colorectal cancer screening and its viability in practice management and a guest commentary that provided tips on separating fact from fiction in a recent report regarding a patient with Crohn’s disease.
Patients with IBD at increased risk for type 2 diabetes
FIT, fecal calprotectin tests can assess recurrence risk in ulcerative colitis
Smoking has no beneficial impact on UC outcomes
Patients with IBD at increased risk for myocardial infarction
5 recent highlights in IBD
Treatment nonadherence predicts escalation in children with ulcerative colitis
Top stories in gastroenterology: FDA issues safety alert for Xeljanz, inflammatory bowel disease increases risk for venous thromboembolism
Among the top stories in gastroenterology last week were the FDA issuing a safety alert and approving a boxed warning for the use of Xeljanz in patients with ulcerative colitis and a study that found patients with inflammatory bowel disease are at increased risk for venous thromboembolism for up two months after discharge from the hospital.